Kitagawa Takehiro, Kitahara Tetsuhiro
Department of Neurosurgery, Saiseikai Yamaguchi General Hospital.
No Shinkei Geka. 2017 Nov;45(11):977-983. doi: 10.11477/mf.1436203632.
A 46-year-old man presented with headache, right hemiparesis, and motor aphasia. A diagnosis of cerebral venous thrombosis with subarachnoid hemorrhage was made. We started intravenous administration of unfractionated heparin. After 6 days in hospital, the right hemiparesis and motor aphasia worsened, and brain computed tomographic(CT)images demonstrated intracerebral hemorrhage in the left parietal lobe. Therefore, we switched treatment from heparin to apixaban. His condition improved and a brain magnetic resonance(MR)venogram after 7 days in hospital showed recanalization of the cerebral veins. He was discharged with no apparent neurological defects 33 days after onset and his modified Rankin Scale score was 1. In cases of progressive cerebral venous thrombosis with intracerebral hemorrhage, during anticoagulation, it is necessary to achieve recanalization of the occluded cerebral vein rapidly without spreading the intracerebral hemorrhage. Factor Xa inhibitors, especially apixaban, may be another option for treating cerebral venous thrombosis with intracerebral hemorrhage.
一名46岁男性出现头痛、右侧偏瘫和运动性失语。诊断为脑静脉血栓形成伴蛛网膜下腔出血。我们开始静脉注射普通肝素。住院6天后,右侧偏瘫和运动性失语加重,脑部计算机断层扫描(CT)图像显示左顶叶脑出血。因此,我们将治疗从肝素改为阿哌沙班。他的病情有所改善,住院7天后脑部磁共振(MR)静脉造影显示脑静脉再通。发病33天后他出院,无明显神经功能缺损,改良Rankin量表评分为1分。在伴有脑出血的进行性脑静脉血栓形成病例中,抗凝期间有必要迅速实现闭塞脑静脉的再通,同时不使脑出血扩散。Xa因子抑制剂,尤其是阿哌沙班,可能是治疗伴有脑出血的脑静脉血栓形成的另一种选择。